Journal of Antimicrobial Chemotherapy (2002) 50, 21-26
© 2002 The British Society for Antimicrobial Chemotherapy
Supplement |
Susceptibility patterns of bacteria causing community-acquired respiratory infections in Spain: the SAUCE project
1 Instituto Valenciano de Microbiología, 2 Department of Microbiology, School of Medicine and University Hospital, Valencia; 3 Medical Department, GlaxoSmithKline, Tres Cantos, Madrid, Spain
Abstract
Multicentre surveillance is essential in order to monitor the prevalence of certain resistance phenotypes and to identify rapidly the emergence of new ones. However, many surveillance studies are based either on a relatively small number of isolates from a single country, or on a large number of isolates from many different countries and so are not equally meaningful. Extensive national multicentre surveillance would provide a more reliable strategy for assessing the extent of antimicrobial resistance in individual countries. This article describes Spanish experience with the surveillance network SAUCE, and summarizes the main results on antimicrobial resistance in the three key bacterial pathogens involved in community-acquired respiratory tract infections in Spain: Streptococcus pneumoniae, Haemophilus influenzae and Streptococcus pyogenes.
Footnotes
Other members of the Spanish Surveillance Group for Respiratory Pathogens are listed in the Acknowledgements.
* Correspondence address. Department of Microbiology, University Hospital and School of Medicine, Avda Blasco Ibañez 17, 46010 Valencia, Spain. Fax: +34-96-356-19-86; E-mail: jglomas{at}retemail.es
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Fenoll, L. Aguilar, O. Robledo, M.-J. Gimenez, D. Tarrago, J.-J. Granizo, M. Gimeno, and P. Coronel Influence of the {beta}-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media J. Antimicrob. Chemother., August 1, 2007; 60(2): 323 - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Alou, M. J. Gimenez, D. Sevillano, L. Aguilar, N. Gonzalez, O. Echeverria, M. Torrico, P. Coronel, and J. Prieto Are {beta}-lactam breakpoints adequate to define non-susceptibility for all Haemophilus influenzae resistance phenotypes from a pharmacodynamic point of view? J. Antimicrob. Chemother., April 1, 2007; 59(4): 652 - 657. [Abstract] [Full Text] [PDF] |
||||
